S100A9 blockade improves the functional recovery after spinal cord injury via mediating neutrophil infiltration

Sun,Feng; Zhang,Haiwei; Huang,Tianwen; Shi,Jianhui; Wei,Tianli; Wang,Yansong

doi:10.3892/etm.2022.11220

S100A9 blockade improves the functional recovery after spinal cord injury via mediating neutrophil infiltration

Authors:
- Feng Sun
- Haiwei Zhang
- Tianwen Huang
- Jianhui Shi
- Tianli Wei
- Yansong Wang
View Affiliations

Affiliations: Department of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150000, P.R. China, Department of Imaging, General Hospital of Heilongjiang General Administration of Agriculture and Reclamation, Harbin, Heilongjiang 150000, P.R. China, Department of Orthopedics, General Hospital of Heilongjiang General Administration of Agriculture and Reclamation, Harbin, Heilongjiang 150000, P.R. China, Department of Orthopaedics, Heilongjiang Provincial Hospital, Harbin, Heilongjiang 150000, P.R. China
Published online on: February 17, 2022 https://doi.org/10.3892/etm.2022.11220
Article Number: 291
Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Spinal cord injury (SCI) refers to damage to the spinal cord resulting from trauma, disease or degeneration. Controlling the inflammatory process and restoring neural homeostasis is hypothesized to prevent injury aggravation. S100 calcium‑binding protein A9 (S100A9) is a pro‑inflammatory alarm protein, which is expressed in and released by activated neutrophils. However, whether S100A9 could serve as an effective target for the treatment of SCI has not been reported to date. In the present study, a T10 spinal cord contusion injury model was established in Sprague‑Dawley rats. S100A9 expression level was determined in the serum and injured spinal cord tissue via ELISA, reverse transcription‑quantitative PCR (RT‑qPCR) and western blotting. The S100A9‑specific blocker, ABR‑238901 (ABR), was administered during the inflammatory phase of SCI, as a form of treatment. Subsequently, the morphological structure, neuronal viability and inflammatory levels of injured spinal cord were observed by histopathology, immunohistochemistry and RT‑qPCR. In the obtained results, S100A9 was found to be highly expressed in the injured spinal cord and serum in the first 3 days after SCI. However, at 28 days after surgery, ABR treatment significantly improved motor function, reduced the cavity formation and neutrophil infiltration in the lesion, which was verified via H&E staining and immunohistochemistry for myeloperoxidase. Furthermore, ABR treatment was found to effectively improve the survival and viability of neurons, as shown via Nissl staining and immunofluorescence of the synaptic plasticity markers, microtubule associated protein 2 and neurofilament 200. Moreover, S100A9 blockade effectively upregulated the mRNA expression level of the anti‑inflammatory genes, IL‑4 and IL‑10 and downregulated the mRNA expression level of the pro‑inflammatory factors, IL‑1β, IL‑6 and TNF‑α. In addition, S100A9 blockade notably alleviated the apoptosis level of the injured nerve cells. Therefore, the findings of the present study revealed that S100A9 may be a useful target for the treatment of SCI.

View Figures

View References

1	Hutson TH and Di Giovanni S: The translational landscape in spinal cord injury: Focus on neuroplasticity and regeneration. Nat Rev Neurol. 15:732–745. 2019.PubMed/NCBI View Article : Google Scholar
2	Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, Morozoff C, Kutz MJ, Huynh C, Barber RM, Shackelford KA, Mackenbach JP, van Lenthe FJ, et al: US county-level trends in mortality rates for major causes of death, 1980-2014. JAMA. 316:2385–2401. 2016.PubMed/NCBI View Article : Google Scholar
3	National SCI Statistical Center: Facts and figures at a glance. University of Alabama at Birmingham, AL, USA, 2019.
4	Ahuja CS, Nori S, Tetreault L, Wilson J, Kwon B, Harrop J, Choi D and Fehlings MG: Traumatic spinal cord injury-repair and regeneration. Neurosurgery. 80 (Suppl 3):S9–S22. 2017.PubMed/NCBI View Article : Google Scholar
5	Jones TB: Lymphocytes and autoimmunity after spinal cord injury. Exp Neurol. 258:78–90. 2014.PubMed/NCBI View Article : Google Scholar
6	Nakamura M, Houghtling RA, Macarthur L, Bayer BM and Bregman BS: Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord. Exp Neurol. 184:313–325. 2003.PubMed/NCBI View Article : Google Scholar
7	Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, Horwood N and Nanchahal J: Alarmins: Awaiting a clinical response. J Clin Invest. 122:2711–2719. 2012.PubMed/NCBI View Article : Google Scholar
8	Pruenster M, Vogl T, Roth J and Sperandio M: S100A8/A9: From basic science to clinical application. Pharmacol Ther. 167:120–131. 2016.PubMed/NCBI View Article : Google Scholar
9	Li Y, Chen B, Yang X, Zhang C, Jiao Y, Li P, Liu Y, Li Z, Qiao B, Bond Lau W, et al: S100a8/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic/reperfusion injury. Circulation. 140:751–764. 2019.PubMed/NCBI View Article : Google Scholar
10	Marinković G, Grauen Larsen H, Yndigegn T, Szabo IA, Mares RG, de Camp L, Weiland M, Tomas L, Goncalves I, Nilsson J, et al: Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction. Eur Heart J. 40:2713–2723. 2019.PubMed/NCBI View Article : Google Scholar
11	Zeng H, Liu N, Yang YY, Xing HY, Liu XX, Li F, La GY, Huang MJ and Zhou MW: Lentivirus-mediated downregulation of α-synuclein reduces neuroinflammation and promotes functional recovery in rats with spinal cord injury. J Neuroinflammation. 16(283)2019.PubMed/NCBI View Article : Google Scholar
12	Zhao B, Lu R, Chen J, Xie M, Zhao X and Kong L: S100A9 blockade prevents lipopolysaccharide-induced lung injury via suppressing the NLRP3 pathway. Respir Res. 22(45)2021.PubMed/NCBI View Article : Google Scholar
13	Basso DM, Beattie MS and Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 12:1–21. 1995.PubMed/NCBI View Article : Google Scholar
14	Bryan H, Timo N and Gemma P: The Cost Manual of Laboratory Animal Care and Use. USA: CRC Press, pp333-353, 2011.
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
16	Wu Q, Wang Q, Li Z, Li X, Zang J, Wang Z, Xu C, Gong Y, Cheng J, Li H, et al: Human menstrual blood-derived stem cells promote functional recovery in a rat spinal cord hemisection model. Cell Death Dis. 9(882)2018.PubMed/NCBI View Article : Google Scholar
17	Kovačić M, Mitrović-Ajtić O, Beleslin-Čokić B, Djikić D, Subotički T, Diklić M, Leković D, Gotić M, Mossuz P and Čokić VP: TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms. Cell Oncol (Dordr). 41:541–553. 2018.PubMed/NCBI View Article : Google Scholar
18	Lorey MB, Rossi K, Eklund KK, Nyman TA and Matikainen S: Global characterization of protein secretion from human macrophages following non-canonical caspase-4/5 inflammasome activation. Mol Cell Proteomics. 16 (Suppl 1):S187–S199. 2017.PubMed/NCBI View Article : Google Scholar
19	Ramer LM, Ramer MS and Bradbury EJ: Restoring function after spinal cord injury: Towards clinical translation of experimental strategies. Lancet Neurol. 13:1241–1256. 2014.PubMed/NCBI View Article : Google Scholar
20	David S, López-Vales R and Wee Yong V: Harmful and beneficial effects of inflammation after spinal cord injury: Potential therapeutic implications. Handb Clin Neurol. 109:485–502. 2012.PubMed/NCBI View Article : Google Scholar
21	Orr MB and Gensel JC: Spinal cord injury scarring and inflammation: Therapies targeting glial and inflammatory responses. Neurotherapeutics. 15:541–553. 2018.PubMed/NCBI View Article : Google Scholar
22	Shah M, Peterson C, Yilmaz E, Halalmeh DR and Moisi M: Current advancements in the management of spinal cord injury: A comprehensive review of literature. Surg Neurol Int. 11(2)2020.PubMed/NCBI View Article : Google Scholar
23	Marino RJ, Ditunno JF Jr, Donovan WH and Maynard F Jr: Neurologic recovery after traumatic spinal cord injury: Data from the model spinal cord injury systems. Arch Phys Med Rehabil. 80:1391–1396. 1999.PubMed/NCBI View Article : Google Scholar
24	Kirshblum S, Millis S, Mckinley W and Tulsky D: Late neurologic recovery after traumatic spinal cord injury. Arch Phys Med Rehabil. 85:1811–1817. 2004.PubMed/NCBI View Article : Google Scholar
25	Enzmann G, Mysiorek C, Gorina R, Cheng YJ, Ghavampour S, Hannocks MJ, Prinz V, Dirnagl U, Endres M, Prinz M, et al: The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury. Acta Neuropathol. 125:395–412. 2013.PubMed/NCBI View Article : Google Scholar
26	Bao F, Chen Y, Schneider KA and Weaver LC: An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury. Exp Neurol. 214:160–167. 2008.PubMed/NCBI View Article : Google Scholar
27	Nguyen HX, O'barr TJ and Anderson AJ: Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha. J Neurochem. 102:900–912. 2007.PubMed/NCBI View Article : Google Scholar
28	Nagareddy PR, Murphy AJ, Stirzaker RA, Hu Y, Yu S, Miller RG, Ramkhelawon B, Distel E, Westerterp M, Huang LS, et al: Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab. 17:695–708. 2013.PubMed/NCBI View Article : Google Scholar
29	Cotoi OS, Dunér P, Ko N, Hedblad B, Nilsson J, Björkbacka H and Schiopu A: Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals. Arterioscler Thromb Vasc Biol. 34:202–210. 2014.PubMed/NCBI View Article : Google Scholar
30	Marinković G, Koenis DS, De Camp L, Jablonowski R, Graber N, de Waard V, de Vries CJ, Goncalves I, Nilsson J, Jovinge S and Schiopu A: S100A9 links inflammation and repair in myocardial infarction. Circ Res. 127:664–676. 2020.PubMed/NCBI View Article : Google Scholar
31	Vogl T, Stratis A, Wixler V, Völler T, Thurainayagam S, Jorch SK, Zenker S, Dreiling A, Chakraborty D, Fröhling M, et al: Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation. J Clin Invest. 128:1852–1866. 2018.PubMed/NCBI View Article : Google Scholar
32	Lin XY, Lai BQ, Zeng X, Che MT, Ling EA, Wu W and Zeng YS: Cell transplantation and neuroengineering approach for spinal cord injury treatment: A summary of current laboratory findings and review of literature. Cell Transplant. 25:1425–1438. 2016.PubMed/NCBI View Article : Google Scholar
33	Li X, Xiao Z, Han J, Chen L, Xiao H, Ma F, Hou X, Li X, Sun J, Ding W, et al: Promotion of neuronal differentiation of neural progenitor cells by using EGFR antibody functionalized collagen scaffolds for spinal cord injury repair. Biomaterials. 34:5107–5116. 2013.PubMed/NCBI View Article : Google Scholar
34	De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, Gunzer M, Roers A and Hogg N: Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood. 121:4930–4937. 2013.PubMed/NCBI View Article : Google Scholar